YORK HOSPITAL
1. Target Overview & Investment Thesis
YORK HOSPITAL is a 54-bed suburban community hospital in YORK, ME with $197.1M in net patient revenue and a -3.6% operating margin. The hospital serves a payer mix of 39.4% Medicare, 8.9% Medicaid, and 51.6% commercial.
Thesis: Turnaround. Our ML models identify $14.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.6% to 3.7% (+736bps).
| Net Revenue HCRIS | $197.1M |
| Current EBITDA COMPUTED | $-7.2M |
| Operating Margin COMPUTED | -3.6% |
| Occupancy HCRIS | 46.7% |
| Revenue / Bed COMPUTED | $3.7M |
| Net-to-Gross HCRIS | 39.3% |
| Distress Probability ML | 47.9% |
2. Market Context & Competitive Position
ME has 38 Medicare-certified hospitals with a median operating margin of -8.3%. The target's margin of -3.6% places it above the state median. Among 15 size-comparable peers (27-108 beds), the median margin is -14.0%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (27-108), prioritizing same-state peers. 15 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| YORK HOSPITAL (Target) | ME | 54 | $197.1M | -3.6% |
| MERCY HOSPITAL | ME | 77 | $240.0M | -11.6% |
| MID COAST HOSPITAL | ME | 93 | $213.6M | -14.0% |
| ST JOSEPH HOSPITAL | ME | 99 | $176.8M | -9.2% |
| PENOBSCOT BAY MEDICAL CENTER | ME | 81 | $171.6M | -21.7% |
| THE AROOSTOOK MEDICAL CENTER | ME | 34 | $134.8M | -23.5% |
| FRANKLIN MEMORIAL HOSPITAL | ME | 46 | $103.4M | -17.3% |
| MAINE COAST MEMORIAL HOSPITAL | ME | 45 | $98.0M | -5.5% |
| SPRING HARBOR HOSPITAL | ME | 96 | $77.6M | -50.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $14.5M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $4.1M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $3.9M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $3.9M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $2.4M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $126K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-7.2M |
| + RCM Uplift | +$14.5M |
| Pro Forma EBITDA | $7.3M |
| Current Margin | -3.6% |
| Pro Forma Margin | 3.7% |
| WC Released (1x) | $7.6M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-11.1M | $97.7M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-11.1M | $103.9M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-9.9M | $148.2M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-9.9M | $158.8M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-12.2M | $28.8M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-12.2M | $27.7M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 15 hospitals with 27-108 beds
- Same-state prioritization (n=16)
- Comp margins: P25=-23.5% / P50=-14.0% / P75=-9.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.